A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of time.
A booster dose of Moderna’s COVID-19 vaccine showed signs of waning antibody levels against the Omicron variant after six months, but the antibodies still remained effective against the variant in laboratory tests, according to a Jan. 26 study in the New England Journal of Medicine.
A new infusion being offered by Duke HomeCare & Hospice. Certain patients who test positive for COVID-19 are eligible for an infusion designed to decrease the risk of transmission, stimulate a stronger immune response, decrease symptoms and make it less likely a recovery in the hospital will be necessary.
COVID-19 may soon evolve from a chaotic and unpredictable pandemic to a more manageable endemic, but will remain dangerous and require people to remain vigilant, safe and responsible.
Provost Kornbluth and Dean Klotman discuss the biology of omicron and how Duke is adapting its policies.
Get vaccinated against COVID-19 or you dramatically increase your risk of ending up on a ventilator and further taxing local hospitals as local cases of the virus surge. That’s the message from chief medical officers from three Triangle health systems during a media briefing Thursday. Watch the briefing here.
Children and staff who repeatedly test negative for COVID-19 after contact with someone who has the illness can safely remain in school if universal masking programs are in place, according to a new “test-to-stay” study report from the ABC Science Collaborative.
The newest COVID-19 variant – omicron – casts a larger shadow each day, driving infection rates up just as millions of Americans prepare to travel for the upcoming holidays. Should people get tested first? Should they hug grandma? Will students coming home from college become huge virus vectors?
Duke Researcher Featured in the NIH Director's Blog for Developing a Way to Gauge the Effectiveness of mRNA Vaccines Against COVID19
The work of research team that includes Dr. David Montefiori of the Duke Human Vaccine Institute is highlighted in the NIH Director's Blog.
A new test can quickly test the ability of antibodies to neutralize spike proteins from different variants of COVID-19 simultaneously. The D4 assay shown here is the Teflon-like technology that makes the test possible.